Schedule 13G ownership disclosure

Mineralys Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 603170101

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Catalys Pacific Fund, LP

    Shares: 8,002,738 · Class: 10.1%

  • Catalys Pacific Fund GP, LP

    Shares: 8,002,738 · Class: 10.1%

  • Catalys Pacific, LLC

    Shares: 8,002,738 · Class: 10.1%

  • Brian Taylor Slingsby

    Shares: 8,002,738 · Class: 10.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-051549
Form type
SCHEDULE 13G/A
Filer
Catalys Pacific Fund, LP
CIK
CIK 1746274
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub